17.02.2021 • NewsChemours

Chemours Splits Fluoroproducts Division

US chemical company Chemours announced on Feb. 11 that it had split its Fluoroproducts segment into two distinct businesses during the fourth quarter of 2020.

The previous fluorochemicals reporting unit has become Thermal & Specialized Solutions (TSS), while the fluoropolymers segment has become Advanced Performance Materials (APM). The latter business includes flagship and industry-leading brands such as Teflon, Viton, Krytox and Nafion.

"Our Fluoroproducts business includes two highly customer-centered units that serve distinctly different customers with very specific needs,” said chief operating officer Mark Newman. “The decision to divide these new segments will allow us to capitalize on the unique market opportunities addressed by solutions from both units, while creating new growth opportunities for our customers.”

The company has also appointed new leaders for the TSS and APM businesses. Alisha Bellezza, vice president of fluorochemicals, will become president of TSS, while Denise Dignam, vice president of fluoropolymers, will be president of APM.

The current Fluoroproducts president, Edwin Sparks, will become president of the Titanium Technologies business, replacing Bryan Snell who will retire.

All appointments are effective from Mar. 1, 2021.

Chemours announced on Feb. 11 that it had split its Fluoroproducts segment into...
Chemours announced on Feb. 11 that it had split its Fluoroproducts segment into two businesses during Q4 2020. The previous fluorochemicals reporting unit has become Thermal & Specialized Solutions, while the fluoropolymers segment has become Advanced Performance Materials. (c) Kaleidico

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.